SI
MRNA icon

Symmetry Investments’s Moderna MRNA Stock Holding History

Symmetry Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,000
Closed -$305K – 182
2026
Q1 		$305K Buy
+6,000
New +$280K 0.03% 113
2025
Q1 		– Sell
-10,162
Closed -$423K – 188
2024
Q4 		$423K Buy
+10,162
New +$486K 0.02% 146

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Symmetry Investments's MRNA Position: Q2 2026 in Review

Symmetry Investments sold out of Moderna (MRNA) in Q2 2026, closing a stake of 6,000 shares — an estimated $305K sold.

Symmetry Investments first reported a position in MRNA in Q4 2024 and held it in 2 quarters. The position peaked at $423K in Q4 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Symmetry Investments reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Symmetry Investments sold 6,000 Moderna shares in Q2 2026, an estimated $305K.
  • Symmetry Investments first reported a position in Moderna in Q4 2024 and held it in 2 quarters.
  • Symmetry Investments's Moderna position peaked at $423K in Q4 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Symmetry Investments's 13F filing for Q2 2026, filed 14 Aug 2026.